PPT-KNOWLEDGE OF MILITATING FACTORS AGAINST BREAST CANCER EARLY
Author : kittie-lecroy | Published Date : 2017-05-18
NIGERIA LAURETTE P N MADU PhD OMICS 4 th International Conference on Nursing amp Healthcare October 7th 2015 background Breast cancer is a malignant tumour
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "KNOWLEDGE OF MILITATING FACTORS AGAINST ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
KNOWLEDGE OF MILITATING FACTORS AGAINST BREAST CANCER EARLY: Transcript
NIGERIA LAURETTE P N MADU PhD OMICS 4 th International Conference on Nursing amp Healthcare October 7th 2015 background Breast cancer is a malignant tumour of breast cells. nbcamorg reast cancer is the second most common kind of cancer in women About 1 in 8 women born today in the United States will get breast cancer at some point The good news is that many women can survive breast cancer if its found and treated earl nbcamorg reast cancer is the second most common kind of cancer in women About 1 in 8 women born today in the United States will get breast cancer at some point The good news is that many women can survive breast cancer if its found and treated earl R. educe Breast Density to Decrease Risk of Breast Cancer. by Sat Dharam Kaur ND. Breast Density and Cancer Risk. Increased breast density causes a 4-5 fold greater risk of breast cancer in women who have increased density in > 75% of breast tissue. DR. A. AKHATOR FWACS, FICS. SENIOR LECTURER DELSU . CONSULTANT SURGEON DELSUTH. PRE-TEST. Breast cancer is the most common cancer in women in Nigeria . Breast cancer is the most common cause of cancer related deaths. Debbie Bajrovic. Oncology Pharmacist. Mount Hospital Pharmacy. ADJUVANT AND NEO-ADJUVANT THERAPY FOR early BREAST CANCER. Adjuvant therapy is any treatment given after primary surgery.. Neo-Adjuvant therapy is any treatment given before primary surgery.. A patient guide . What is Breast Density?. Breast . Density refers to the amount of fatty tissue and fibro-glandular tissue seen in the breast by mammogram. This is not something that can be felt on clinical breast exam. Breast Density is categorized into four different levels. . Rachna Raman MD MS. Hematology and Medical Oncology. Bon Secours Cancer Institute at St. Mary’s Hospital. Objectives. Risk factors . Screening guidelines and controversies. Screening and management of patients at high risk for breast cancer. Caribbean Hematology Oncology Center. Cancer statistics, 2018. Cancer statistics, 2018, Volume: 68, Issue: 1, Pages: 7-30, First published: 04 January 2018, DOI: (10.3322/caac.21442) . Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. Inspection. Size. S. ymmetry (some variation is normal) . Shape. Contour (flattening, masses, and dimpling). S. kin (color, edema, rashes, thickening, and venous pattern). S. cars (previous surgery, injuries). Edmund Tai, MD. Hematology/Oncology. PAMF. American Cancer Society Cancer Prevention . Study-II. Harvard . Nurses' Health Study (NHS. ). Hawaii-Los . Angeles Multiethnic . Cohort. Prostate. , Lung, Colorectal and Ovarian Cancer . group. of diseases. . All forms of cancer cause cells in the body to change and grow out of control. . Most types of cancer cells form a lump or mass called a . tumor. . . The tumor can invade and destroy healthy tissue. Cells from the tumor can break away and travel to other parts of the body. There they can continue to grow. . March 2019. Preview/Introduction. The Risk of Breast Cancer to Women. Does Mammography Save Lives?. When to Start and How Often Should Women Screen?. Risks Versus Benefits of Mammography. Breast Cancer: The Impact on Women. Azeez Farooki, MD. Attending Physician, Clinical Member. Memorial Sloan Kettering Cancer Center. New York, NY. Objectives. Elucidate the problem of aromatase inhibitor induced bone loss and increased risk of fractures in breast cancer. breast tissue, . most . commonly from the inner lining . of. milk ducts or the lobules that supply the . ducts . with . milk.. Breast cancer may be invasive or noninvasive. . Invasive.
Download Document
Here is the link to download the presentation.
"KNOWLEDGE OF MILITATING FACTORS AGAINST BREAST CANCER EARLY"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents